Parenting Patch on MSN
Eating disorders in boys can be overlooked, here's what to watch for
... Read more ...
Musculoskeletal (MSK) disorders affect the muscles, bones, joints, and tissues. In children, they may be due to infection, cancer, inflammatory arthritis, or progressive muscle disorders. MSK ...
Neurological disorders affect the function of the nervous system. Common pediatric neurological disorders include ADHD, autism spectrum disorder, epilepsy, and cerebral palsy. Neurological disorders ...
Researchers have developed a tool for identifying children at risk of speech disorders, reducing unnecessary treatment for common speech errors that often resolve on their own. The research, led by ...
Bones called vertebrae make up your spine. Muscles and ligaments connect your vertebrae to each other. Between the vertebrae lie soft, flat discs that provide cushioning and support. Each vertebra ...
Specialists at U of U Health provide the treatment you need for your child’s thyroid issues. If you believe your child has symptoms of a thyroid disorder or you are referred from your pediatrician, ...
Please provide your email address to receive an email when new articles are posted on . Disorders of gut-brain interaction cause symptoms throughout the digestive tract including pain, changes in ...
Clinicians, researchers and activists have stressed the need for better treatment and services of people with eating disorders who don’t fit the stereotypical patient profile — and recent data ...
Histiocytic disorders in children are marked by the abnormal proliferation of cells from the mononuclear phagocyte system, which includes dendritic cells, monocytes, and macrophages. These cells, ...
Stimulant treatment in children with ADHD can lead to serious adverse events, including psychosis and mania, particularly in those with comorbid BPD. Children with BPD exposed to stimulants experience ...
InvestorsHub on MSN
Spruce Biosciences reports positive FDA meetings as it prepares TA-ERT filing for rare pediatric disorder
Spruce Biosciences, Inc. (NASDAQ:SPRB) said it has completed two Type B meetings with the U.S. Food and Drug Administration (FDA), clearing key regulatory discussions ahead of its planned biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results